Look for any podcast host, guest or anyone
Showing episodes and shows of

Martin Slezak

Shows

Daily Soap Opera Spoilers by Soap Dirt (GH, Y&R, B&B, and DOOL)Daily Soap Opera Spoilers by Soap Dirt (GH, Y&R, B&B, and DOOL)General Hospital Early Spoilers Aug 11-15: Jason a Hero & Michael Digs | Soap DirtClick to Subscribe: https://bit.ly/Youtube-Subscribe-SoapDirt General Hospital, ABC's beloved soap opera, has an exciting week as spoilers for August 11-15, 2025 see Jason Morgan (Steve Burton) takes on the heroic role and Michael Corinthos (Rory Gibson) dives into some serious investigating. Notable moments include Lulu Spencer's (Alexa Havins) request to Carly Corinthos Spencer (Laura Wright) about keeping Leisl Obrecht (Kathleen Gati) away from Rocco Falceroni (Finn Carr), and Chase's (Josh Swickard) confrontation with Michael over his decision to keep Willow Tait (Katelyn MacMullen) away from the kids. GH spoilers see as tensions rise, Jason...2025-08-0708 minDaily Soap Opera Spoilers by Soap Dirt (GH, Y&R, B&B, and DOOL)Daily Soap Opera Spoilers by Soap Dirt (GH, Y&R, B&B, and DOOL)General Hospital Early Spoilers Aug 11-15: Jason a Hero & Michael Digs | Soap DirtClick to Subscribe: https://bit.ly/Youtube-Subscribe-SoapDirt General Hospital, ABC's beloved soap opera, has an exciting week as spoilers for August 11-15, 2025 see Jason Morgan (Steve Burton) takes on the heroic role and Michael Corinthos (Rory Gibson) dives into some serious investigating. Notable moments include Lulu Spencer's (Alexa Havins) request to Carly Corinthos Spencer (Laura Wright) about keeping Leisl Obrecht (Kathleen Gati) away from Rocco Falceroni (Finn Carr), and Chase's (Josh Swickard) confrontation with Michael over his decision to keep Willow Tait (Katelyn MacMullen) away from the kids. GH spoilers see as tensions rise, Jason...2025-08-0708 minBizNexus RoundupBizNexus RoundupWarren Buffets reflections on M&AThe provided text offers Warren Buffett's 2019 reflections on mergers and acquisitions (M&A), originally shared in a Berkshire Hathaway letter to shareholders. Buffett emphasizes that even initially promising deals can falter, likening acquisitions to marriages where pre-nuptial expectations often differ from reality.He advises rigorous evaluation over romanticized views during corporate courtships, as buyers frequently encounter unforeseen challenges. Finally, Buffett suggests that spreading investments across various businesses allows successful ventures to grow and absorb more capital over time, ultimately improving overall returns. The text also includes a brief...2025-08-0412 minCures & CapitalCures & CapitalDr. Andrée Bates on AI that works: from pilot chaos to real impactIn this episode, we talk to Dr. Andrée Bates, founder and CEO of Eularis, a company helping clients accelerate pharma business results through Artificial Intelligence.We explore how the biopharma industry can move beyond scattered pilots toward strategic, enterprise-wide AI integration. Drawing on decades at the forefront of AI in pharma, Dr. Bates shares practical insights on building the foundations for long-term value creation and turning AI into a true competitive advantage. We also dig into how to calculate ROI on AI, avoid the “spray and pray” trap, and why the future of pharm...2025-06-261h 18Cures & CapitalCures & CapitalLeon 'Jun' Tang: Inside the Rise of China's Biotech IndustryHow did China become a serious force in global biotech in just over a decade?This is the insider story of China's biotech boom!Dr. Leon 'Jun' Tang, founding partner of InScienceWeTrust BioAdvisory, joins Cures & Capital to unpack the rise of Chinese biopharma.From talent migration and government planning to innovation in ADCs and the challenges of commercialization.Chapters00:00 - Introduction & Leon’s global background01:13 - Guest introduction - Leon 'Jun' Tang05:35 - Impact of Chinese biotech innovation at biomedical conferences...2025-06-101h 18Cures & CapitalCures & CapitalJason O'Neill on cracking the code to successful drug launches - Part 2In this episode, we talk to Jason O’Neill, former CEO of Dendreon and Iridium Therapeutics, and author of The Secrets of Successful Drug Launches.This conversation is a practical guide to new drug launches, packed with Jason's hard-won insights. We explore why so many launches fail, the psychology behind adoption resistance, what meaningful relative advantage really means, how to plan for a successful launch, and when you actually need to start thinking about commercialization.This episode will shift how you think about launching new drugs, and what it truly takes to do it successfully....2025-05-2852 minCures & CapitalCures & CapitalJason O'Neill on cracking the code to successful drug launches - Part 1In this episode, we talk to Jason O’Neill, former CEO of Dendreon and Iridium Therapeutics, and author of The Secrets of Successful Drug Launches.This conversation is a practical guide to new drug launches, packed with Jason's hard-won insights. We explore why so many launches fail, the psychology behind adoption resistance, what meaningful relative advantage really means, how to plan for a successful launch, and when you actually need to start thinking about commercialization.This episode will shift how you think about launching new drugs, and what it truly takes to do it successfully....2025-05-2142 minCures & CapitalCures & CapitalEpisode 9 - Reflections and TakeawaysOver the past few months, we’ve had the chance to speak with some of the sharpest minds in the industry—thinkers and practitioners who have shaped how we understand drug innovation, R&D productivity, portfolio strategy, and other critical topics.In this episode, we bring together the major insights and lessons, highlighting patterns that emerged across the different conversations.We also spotlight the unique takeaways from each guest to help ensure these key learnings really stick. Whether you're an R&D leader, investor, innovator, or strategist, these insights will help you rethink how to crea...2025-05-0733 minCures & CapitalCures & CapitalAaron Schacht on the pharmaceutical industry's grand challenge and managing R&D at scaleIn this episode, we talk to Aaron Schact, the CEO and Board Director at BiomEdit and former R&D leader at Eli Lilly and Elanco. We discuss how to improve biopharma's R&D productivity and the industry's "grand challenge", why R&D productivity is the mental model for managing R&D at scale, practical advice on how to approach and work with R&D productivity, and much more!If you want to connect with us - we would love to hear from you:Linkedin: https://www.linkedin.com/company/cures-capital-podcastIf you p...2025-04-2253 minCures & CapitalCures & CapitalMatthias Krings on crafting winning biopharma strategies and smart decisionsIn this episode, our guest is Dr. Matthias Krings - a senior partner at Catenion, a biopharma strategy consulting firm.Matthias is a seasoned veteran in biopharma strategy.In this conversation, he shares his playbook for achieving success as a biopharma company.As critical pillars for biopharma success, we dive into strategy processes, decision-making, and effective R&D risk management.If you want to connect with us - we would love to hear from you:LinkedIn: https://www.linkedin.com/company/cures-capital-podcastYou can also watch the...2025-04-0749 minCures & CapitalCures & CapitalStephan Christgau on applying the VC mindset in biotech & pharmaHow do venture capitalists think? And how do they define and create value in the life science industry?In this episode, we talk to Stephan Christgau, founding partner of Eir Ventures, about the VC mindset, investment decision-making and portfolio strategy. We dive into how VCs assess risk, balance high-stakes opportunities, and what could pharma and biotech companies learn from the VC way of doing things.If you want to connect with us - we would love to hear from you:Linkedin: https://www.linkedin.com/company/cures-capital-podcastIf you prefer to get...2025-03-201h 03Cures & CapitalCures & CapitalMurray Aitken's guide to biotech & pharma leaders: Navigating great uncertainty and complexityIn this episode, we sit down with Murray Aitken, Executive Director of the IQVIA Institute for Human Data Science, to discuss the trends shaping the life sciences industry in 2025 and beyond.How do we navigate the life sciences industry in times of great uncertainty?Murray has observed the life sciences industry for decades and lays out his balanced perspective of the state of the industry and the underlying uncertainties, challenges and opportunities. This episode is a must-watch for anyone who wants to know what is going on in the industry. If you want t...2025-03-041h 00Cures & CapitalCures & CapitalMike Rea on why pharma struggles with innovation - and how to fix itIn this episode, Mike Rea - CEO, IDEA Pharma - takes us on a journey through innovation and value creation in pharma. It is not all roses!He shares his candid views on what the pharmaceutical industry needs to do better to be less confused about innovation.Mike Rea also explains the importance of getting the definition of innovation right in drug development. Early commercial involvement in drug R&D is another key pillar in his drug innovation philosophy.We also get to discuss organizational design and team size conducive to unlocking pharma's...2025-02-181h 08Cures & CapitalCures & CapitalKelvin Stott on what it takes to fix pharma's broken business modelIn this episode, Kelvin Stott talks about why might be pharma's business model broken and how can it be fixed, the declining ROI on drug R&D, better R&D portfolio decision making, raising the bar in pharma/biotech innovation and more. Kelvin Stott has over 20 years of diverse leadership experience in pharma R&D strategy and operations, drug discovery and development, portfolio management, strategy consulting, biotech start-ups and venture capital. Currently, he is the Founder and CEO of Amporin Pharmaceuticals.If you want to connect with us:Linkedin: https://www.linkedin.com/company/c...2025-02-021h 00Cures & CapitalCures & CapitalJack Scannell on drug R&D decision-making: The value of getting it rightIn this episode, Dr. Jack Scannell delves into topics such as R&D productivity, decision-making, model validity, and more.If you're looking to deepen your understanding of these areas, there's no better guide than Jack.Jack brings a deep and holistic understanding of the biotech and pharma industry, having held a variety of roles—including being a neuroscientist, strategy consultant, investment analyst, and now the CEO of Etheros Pharmaceuticals.Chapters:00:00 Intro02:08 Guest introduction - Dr. Jack Scannell05:46 R&D productivity from past to present to future34:00 Decision making, model va...2025-01-211h 18Cures & CapitalCures & CapitalCures & Capital: Trailer EpisodeEPISODE 1 - Cures & Capital: Trailer EpisodeIn this episode, we introduce the scope and mission of the podcast.Our focus with Cures & Capital is the intersection between drug R&D and finance. Hosts: Martin Slezak & Simon Birksø.Disclaimer: This podcast and activities related to it are completely independent from our day jobs. All the views and opinions expressed through this channel are solely our own and do not represent or in any way reflect the views and opinions of the companies we work for.2025-01-1103 minTotally PreventableTotally Preventable100th Episode Colby MartinPaws and Recovery – pawsandrecovery.com Susan MaresettiBe Smart for Kits – besmartforkids.org Stacy DuboisGet Rooted Recovery – getrooted.us Elizabeth McGannGirls on the Run – GOTRRI.org Heidi List-MurphyThe List Academy of Music – Thelistacademyofmusic.org Shannon Dos SantosThe Village RI – RIvillage.org Lisa Bigney and Halley LavensteinRI Tutorial and Education Services – RItutorial.org Erica HansonRIDOH Community Health Network – health.ri.gov/programs/ Sam SlezakButler, Memory a...2024-12-0632 minPodcast ConversacinesPodcast ConversacinesConversacines 194 - Esta tierra es mía (Jean Renoir 1943)Albert Lory (Charles Laughton) es un profesor de escuela en una ciudad de un país indeterminado ocupado por el ejército Nazi durante la II Guerra Mundial. Enamorado de su compañera de trabajo y vecina, la también profesora Louise Martin (Maureen O’Hara), Albert se siente frustrado al ser incapaz de declararse por su carácter acobardado. Esta cobardía es también motivo de burla de sus propios alumnos. Para colmo, Louise mantiene una relación con un hombre llamado George Lambert (George Sanders). Cuando una serie de acontecimientos provocan que Albert sea detenido por los soldados a...2024-06-2255 minMajor League Eventing PodcastMajor League Eventing PodcastBradley Champagne - Canadian 3* EventerKaren and Robby get to know Canadian Eventer, Bradley Champagne. Brad is a previous guest from episode #25 with the Windurra Crew. Brad shares his story of growing up in Canada and spending a winter in Ocala, Fl with Karl Slezak. Brad eventually became a rider for Boyd Martin and found his calling of breaking and training the young horses and getting them to the YEH Championships.  Brad has gone to Ireland for the 2nd year in a row and brought back a couple nice horses through the Excel Star Sporthorses. PC: Amy DragooFollow Brad's j...2024-01-0343 minThe Clyborn and Chloe ShowThe Clyborn and Chloe ShowThe Clyborn and Chloe Show - episode 616Greetings Earth Dwellers! This week's show finds Clyborn & Chloe both at Clyborn's bungalow in San Francisco, CA. They welcome into the studio the kings of WNY ambient music...Cosmic Oases! This band consists of Barry DiGregorio, John Martini and Bruce Blair. They bring in with them their new CD that was just released last week. It's entitled Psychedelic Amusement Park. They sit on the "Couch Of Truth" and spill the beans about their past, present and future in the music business. They also play tunes from their new album. Other WNY bands/artists feaured in this show are as follows...2023-07-012h 21Daytime ConfidentialDaytime ConfidentialDC #374: ABC Casting BloodbathOn today's ABC episode of Daytime Confidential Luke and Tina are joined by Eye on Soap's Belinda and Karen from Wubs.net to discuss the latest in All My Children, General Hospital and One Life to Live news including...Greenlee's funeral on All My Children at the Fusion bar. Ricky Paull Goldin's Jake Martin. Is this David Hayward the real David Hayward? Rumors that the Cortlandt mansion is burning down.General Hospital's possible casting bloodbath. What this means for Leslie Charleson, Megan Ward, Greg Vaughan, Rebecca Herbst and Rick Hearst. Constance Towers is returning as Helena...2009-03-1140 min